Paul L. Berns, President and CEO at Anacor Pharmaceuticals, Inc. (ANAC), sold 4,986 shares at $110.97 ($560K) on 2016-01-04, disclosed to the SEC on 2016-01-05.
Open-market sale of $560k ANAC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.97 | 80 | $9K | 1.6% |
| 2 | $112.33 | 2,220 | $249K | 44.5% |
| 3 | $112.33 | 2,220 | $249K | 44.5% |
| 4 | $112.98 | 233 | $26K | 4.7% |
| 5 | $112.98 | 233 | $26K | 4.7% |
| Total | $112.37 avg | 4,986 |
| $560K |
| 100% |
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |